Teachers Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $342K | Buy |
261,290
+75,839
| +41% | +$99.3K | ﹤0.01% | 2676 |
|
|
2018
Q4 | $169K | Sell |
185,451
-26,519
| -13% | -$24.2K | ﹤0.01% | 2879 |
|
|
2018
Q3 | $436K | Buy |
211,970
+35,336
| +20% | +$72.7K | ﹤0.01% | 2688 |
|
|
2018
Q2 | $318K | Hold |
176,634
| – | – | ﹤0.01% | 2850 |
|
|
2018
Q1 | $416K | Hold |
176,634
| – | – | ﹤0.01% | 2611 |
|
|
2017
Q4 | $332K | Hold |
176,634
| – | – | ﹤0.01% | 2747 |
|
|
2017
Q3 | $439K | Buy |
176,634
+27,278
| +18% | +$67.8K | ﹤0.01% | 2645 |
|
|
2017
Q2 | $412K | Buy |
149,356
+12,003
| +9% | +$33.1K | ﹤0.01% | 2689 |
|
|
2017
Q1 | $415K | Buy |
137,353
+19,792
| +17% | +$59.8K | ﹤0.01% | 2623 |
|
|
2016
Q4 | $371K | Hold |
117,561
| – | – | ﹤0.01% | 2690 |
|
|
2016
Q3 | $401K | Buy |
117,561
+11,280
| +11% | +$38.5K | ﹤0.01% | 2583 |
|
|
2016
Q2 | $243K | Buy |
106,281
+13,960
| +15% | +$31.9K | ﹤0.01% | 2794 |
|
|
2016
Q1 | $232K | Sell |
92,321
-7,755
| -8% | -$19.5K | ﹤0.01% | 2741 |
|
|
2015
Q4 | $331K | Buy |
100,076
+9,165
| +10% | +$30.3K | ﹤0.01% | 2642 |
|
|
2015
Q3 | $220K | Hold |
90,911
| – | – | ﹤0.01% | 2843 |
|
|
2015
Q2 | $266K | Buy |
90,911
+3,269
| +4% | +$9.57K | ﹤0.01% | 2889 |
|
|
2015
Q1 | $352K | Hold |
87,642
| – | – | ﹤0.01% | 2634 |
|
|
2014
Q4 | $264K | Hold |
87,642
| – | – | ﹤0.01% | 2782 |
|
|
2014
Q3 | $222K | Hold |
87,642
| – | – | ﹤0.01% | 2832 |
|
|
2014
Q2 | $216K | Buy |
87,642
+21,236
| +32% | +$52.3K | ﹤0.01% | 2901 |
|
|
2014
Q1 | $176K | Hold |
66,406
| – | – | ﹤0.01% | 2922 |
|
|
2013
Q4 | $193K | Hold |
66,406
| – | – | ﹤0.01% | 2876 |
|
|
2013
Q3 | $204K | Buy |
66,406
+6,795
| +11% | +$20.9K | ﹤0.01% | 2800 |
|
|
2013
Q2 | $191K | Buy |
+59,611
| New | +$191K | ﹤0.01% | 2789 |
|